facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita to present at the 17th Annual BIO CEO & Investor Conference 2015

    Krakow, 28 January 2015 - Selvita S.A. (WSE: SLV), the largest drug discovery company in Central and Eastern Europe, today announced that Pawel Przewiezlikowski, Chief Executive Officer of the company, will present at the upcoming 17th Annual BIO CEO…

    Read More...

  • Selvita has raised PLN 27.3 MM on its way to the main market of the Warsaw Stock Exchange

    Krakow, 16 December 2014 - Selvita, Poland-based integrated drug discovery partner for the pharmaceutical and biotechnology industry, has successfully completed its Initial Public Offering. Gross proceeds from the sale of 2,651,891 new shares amount…

    Read More...

  • Felicitex Therapeutics and Selvita initiate strategic collaboration to target cancer quiescence

    Cambridge, MA and Krakow, Poland, 7 November 2014 - Felicitex Therapeutics, a leader in the diagnostics and development of therapeutics for quiescent cancers, and Selvita (PL: SLV), the largest drug discovery company in Central and Eastern Europe, an…

    Read More...